The ultra-low temperature freezer market is expected to grow from US$ 619.89 million in 2022 to US$ 902.08 million by 2030; it is anticipated to register a CAGR of 4.8% from 2022 to 2030.

Download Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007339/

Ultra-Low temperature freezers are designed to store biological materials such as viruses, bacteria, eukaryotic cells, blood, and semen. These freezers are used in blood banks, hospitals, epidemic prevention services, research institutes, and biomedical engineering facilities. These are available in different specifications to suit specific commercial needs. For instance, the plasma is used for storage of blood and plasma products at -30°C to 40°C, and the ultra-low temperature freezers are used for long-term storage of DNA and RNA samples products at a range of 70°C to 80 °C. Rise in R&D activities to introduce new drug compounds, increasing demand for blood & blood components, and rising government support for research activities and clinical trials drive the segment’s growth. In addition, the availability of advanced products by market players is further driving the growth of the market. For instance, Thermo Scientific Revco RLE -86°C upright freezers are available in five capacities, storing 300 up to 700 2-inch boxes. These freezers provide outstanding thermal performance, safety, and security.

Government Support for Research Activities and Clinical Trials creates an opportunity for the growth of the Ultra-Low Temperature Freezer Market.

There has been a vast increase in clinical trials in the last 10 years. In August 2019, the US Food and Drug Administration (FDA) announced 12 new clinical trial research grants for principal investigators from academia and industry across the country. Thus, it plans to grant more than US$ 15 million over the next four years to enhance the development of medical products for patients with rare diseases. The FDA awarded these grants through the Orphan Products Clinical Trials Grants Program, funded by Congress, to encourage the clinical development of drugs, biologics, medical devices, and medical food for the treatment of rare diseases. The grants are further intended to substantially contribute to the marketing approval of rare disease treatment products or to provide essential data needed for the development of such products. For more than 35 years, the FDA has been providing much-needed financial support for clinical trials of potentially life-changing treatments for patients with rare diseases. To date, the Orphan Products Clinical Trials Grants Program’s grants have supported research that led to the marketing approval of more than 60 treatments for rare diseases. Pharmaceutical companies focus on R&D to introduce new molecules for various therapeutic applications with enhanced medical and commercial potential. Moreover, significant investments in R&D activities enable them to deliver high-quality and innovative products, which is expected to fuel the growth of the ultra-low temperature freezer market in the forecast period.

The ultra-low temperature freezer market is divided on the basis of type, application, technology, and geography. The ultra-low temperature freezer market, by type, is bifurcated into chest freezers and upright freezers. The ultra-low temperature freezer market, by application, is segmented into blood & blood products, organs, pharmaceuticals, forensic & genomic research, and others. The market, by technology, is bifurcated into automatic and semi-automatic.

About Us:

The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us

The Insight Partners

Phone: +1-646-491-9876

E-mail: [email protected]